Michael A. Metzger - Insider Trading & Ownership

Location
C/O Syndax Pharmaceuticals, Inc., 400 Totten Pond Road,, Waltham, MA
Summary
The estimated net worth of Michael A. Metzger is at least $4.94M dollars as of September 8, 2025. Michael A. Metzger is the Chief Executive Officer, Director of Syndax Pharmaceuticals Inc and owns shares of Syndax Pharmaceuticals Inc (SNDX) stock worth about $4.9M. Michael A. Metzger is the Director of Pyxis Oncology, Inc. and owns shares of Pyxis Oncology, Inc. (PYXS) stock worth about $36.2K.
Signature
/s/ Michael A. Metzger
All Insider Reports
All Insider Reports

Ownership of Michael A. Metzger

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SNDX Syndax Pharmaceuticals Inc Chief Executive Officer, Director $4.9M -$2.98M -37.8% Sep 8, 2025
PYXS Pyxis Oncology, Inc. Director $36.2K Mar 31, 2025
CTIC CTI BIOPHARMA CORP Director Jun 26, 2023

Insider Transactions Reported by Michael A. Metzger:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.